Lumbar Plexus Catheter Versus Femoral Nerve Catheter for Postoperative Pain After Anterior Cruciate Ligament (ACL) Repair
1 other identifier
interventional
114
1 country
1
Brief Summary
Randomized trial comparing lumbar plexus catheter versus femoral nerve catheter (single-shot femoral block as control group) for postoperative pain control after anterior cruciate ligament repair in children (age 11-21). Primary outcome is pain scores for the first 72 hours. Secondary outcomes include opioid consumption, incidence of opioid side effects and quality of recovery (previously validated scale). Our hypothesis is that lumbar plexus catheter will provide superior pain control and overall quality of recovery compared to femoral nerve catheters.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for not_applicable postoperative-pain
Started Apr 2010
Longer than P75 for not_applicable postoperative-pain
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
February 11, 2010
CompletedFirst Posted
Study publicly available on registry
February 12, 2010
CompletedStudy Start
First participant enrolled
April 1, 2010
CompletedPrimary Completion
Last participant's last visit for primary outcome
September 1, 2012
CompletedStudy Completion
Last participant's last visit for all outcomes
September 1, 2012
CompletedAugust 26, 2010
August 1, 2010
2.4 years
February 11, 2010
August 24, 2010
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Postoperative pain scores
72 hours
Secondary Outcomes (3)
Quality of recovery
72 hours
Opioid consumption
72 hours
Opioid side effects
72 hours
Study Arms (3)
Lumbar plexus catheter
ACTIVE COMPARATORfemoral nerve catheter
ACTIVE COMPARATORsingle-shot femoral block
ACTIVE COMPARATORInterventions
lumbar plexus catheter with 0.2% ropivacaine at 0.15 ml/kg/hr (max 10 ml/hr)
femoral nerve catheter with 0.2% ropivacaine at 0.15 ml/kg/hr (max 10 ml/hr)
single-shot femoral block with 0.2% ropivacaine 0.3 ml/kg (max 20 ml)
Eligibility Criteria
You may qualify if:
- ASA physical status 1-2
- Age 11-21
- Undergoing anterior cruciate ligament repair
You may not qualify if:
- Patient refusal
- Coagulopathy
- Systemic infection or infection at needle insertion site
- Allergy to ropivacaine or opioids
- Taking chronic opioids
- Unavailable by phone
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Seattle Children's Hospital
Seattle, Washington, 98105, United States
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Felicia M Birch, MD
Seattle Children's Hospital
Central Study Contacts
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- SINGLE
- Who Masked
- OUTCOMES ASSESSOR
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
Study Record Dates
First Submitted
February 11, 2010
First Posted
February 12, 2010
Study Start
April 1, 2010
Primary Completion
September 1, 2012
Study Completion
September 1, 2012
Last Updated
August 26, 2010
Record last verified: 2010-08